Trilogy Capital Inc.
Source: SEC Form 13F · as of Mar 2026Trilogy Capital Inc. holds 14 biotech & pharma companies tracked by BioSniper, totaling $27.1M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$27.1M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 5,436 | $5.0M |
| MRKMerck & Co., Inc. | 41,081 | $4.9M |
| ABBVAbbVie Inc. | 21,426 | $4.7M |
| GILDGILEAD SCIENCES, INC. | 31,249 | $4.4M |
| AMGNAMGEN INC | 10,135 | $3.6M |
| JNJJOHNSON & JOHNSON | 5,105 | $1.2M |
| PMPhilip Morris International Inc | 5,659 | $936K |
| MCKMcKesson Corporation | 636 | $550K |
| ABTABBOTT LABORATORIES | 5,256 | $540K |
| CAHCardinal Health Inc. | 1,920 | $406K |
| BMYBRISTOL MYERS SQUIBB CO | 5,654 | $343K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,221 | $330K |
| CORCencora Inc. | 776 | $244K |
| HUMAHumacyte Inc. | 37,800 | $23K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.